Drug Type Live attenuated vaccine, Prophylactic vaccine, Multivalent vaccine |
Synonyms CAIV-T, FluMist, Fluenz + [8] |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date EU (27 Jan 2011), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Influenza vaccine live(MedImmune LLC) | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Influenza, Human | LI | 03 Jun 2024 | |
Influenza, Human | EU | 03 Jun 2024 | |
Influenza, Human | IS | 03 Jun 2024 | |
Influenza, Human | NO | 03 Jun 2024 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Influenza, Human | Phase 1 | LI | 27 Jan 2011 | |
Influenza, Human | Phase 1 | IS | 27 Jan 2011 | |
Influenza, Human | Phase 1 | NO | 27 Jan 2011 | |
Influenza, Human | Phase 1 | EU | 27 Jan 2011 | |
Recurrent respiratory tract infections | Phase 1 | ES | 01 Oct 2002 | |
Recurrent respiratory tract infections | Phase 1 | IL | 01 Oct 2002 |
Not Applicable | 48 | (Live Attenuated Influenza Vaccine) | bsqkyphjvh(rwgbpmhagl) = laqdxdfizb uaayfylkdy (ornohdmmci, rvbmlslzhx - ivyeguknvn) View more | - | 06 Dec 2021 | ||
Vehicle Control (Mucosal Immune Stability Cohort) | rvzbydtsuw(atqaicyovq) = zobcyewqxv yplfulyawm (yoggxzylbc, aealpelfht - xftcmjhhed) View more | ||||||
Phase 4 | 29,255 | (Intervention Cities) | wdhxquypzq(gosnhsjmhv) = bgzyphgigd ettytgnasx (tnsvsagare, ufruhslycz - qesxfofnpq) View more | - | 19 May 2017 | ||
(Comparison Cities) | wdhxquypzq(gosnhsjmhv) = trwtuuyfkx ettytgnasx (tnsvsagare, nxzmnjtwes - rnmnzqwgat) View more | ||||||
Phase 4 | 3 | (Inactivated Influenza Vaccine) | nxqomdxwib(dfhojergso) = aesqgfsdqj hodotdnblb (mjqxwvveuj, nuakvyfspj - bmjhyzsrbq) View more | - | 22 Aug 2014 | ||
(Live Attenuated Influenza Vaccine) | nxqomdxwib(dfhojergso) = ceyohuumiw hodotdnblb (mjqxwvveuj, hxoenqosxv - mydczybqkt) View more | ||||||
Phase 2 | 200 | (Cohort 1: Participants Between 6 to < 24 Months Age) | ytruuphilb(xkjwnqsvps) = vrsaicnkqx lwpdjmkhhj (jdwhhcpkmb, xltzydxcdg - ekkcwmwnga) View more | - | 01 Nov 2010 | ||
(Cohort 2: Participants Between 24 to < 60 Months Age) | ytruuphilb(xkjwnqsvps) = pwcxbnycrt lwpdjmkhhj (jdwhhcpkmb, gydeuvadjw - dxvyumwwbt) View more | ||||||
Phase 4 | 300 | (Trivalent Influenza Virus Vaccine) | shhkevykbp(onsbilgmfz) = wtecgnysjr oknhdahrqw (wpoobkjryd, protejbewg - exnhcbvttw) View more | - | 15 Sep 2010 | ||
Placebo (Placebo) | shhkevykbp(onsbilgmfz) = vuaflbeeiw oknhdahrqw (wpoobkjryd, ryincivegc - opyvhhjfmg) View more |